NEVVI Medicare utilization intelligence
or

← back

Provider profile

MURASE, JENNY M.D.

Dermatology · NPI 1346371382 · MOUNTAIN VIEW, CA

1
Groups
16
Codes · 2024
4,363
Disclosed services

MURASE, JENNY is a Dermatology in MOUNTAIN VIEW, CA, a member of 1 medical group, who billed 16 distinct codes to Medicare Part B in 2024.

Groups: SUTTER BAY MEDICAL FOUNDATION (PALO ALTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

4,363
disclosed services
16
codes billed to Medicare Part B
Prior year · CY2023 4,061 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
95044 Test for allergy using skin patch
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
17110 Destruction of skin growth, 1-14 growths
11102 Biopsy of related skin growth, first growth
96900 Application of ultraviolet light to skin
11103 Biopsy of related skin growth, each additional growth
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11104 Punch biopsy, first skin growth
11105 Punch biopsy, each additional skin growth
17004 Destruction of precancer skin growth, 15 or more growths

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.